|
2020
|
Invention
|
Hygiene detection device and use thereof for monitoring hygiene compliance. The present specifica... |
|
2016
|
Invention
|
Intermittent fibrate administration method. The present specification discloses compositions comp... |
|
2015
|
Invention
|
Compositions, methods and uses for treating gender-biased immune disorders.
The present specific... |
|
|
Invention
|
Compositions, methods and uses for treating gender-biased immune disorders. The present specifica... |
|
2013
|
Invention
|
Drug combinations containing statins for treating cardiovascular diseases. The present specificat... |
|
|
Invention
|
Drug combinations and methods for reducing or maintaining cholesterol or hdl/ldl levels. The pres... |
|
2012
|
Invention
|
Use of b-aminoalcohols in the treatment of inflammatory disorders and pain.
A compound for thera... |
|
|
Invention
|
Treatment of neurodegenerative diseases.
The present specification discloses beta-amino alcohols... |
|
|
Invention
|
Drug combinations and uses in treating a coughing condition. The present specification discloses ... |
|
|
Invention
|
Compostions and methods for treating chronic inflammation and inflammatory diseases. The present ... |
|
|
Invention
|
Compositions and methods for treating cardiovascular diseases. The present specification disclose... |
|
2011
|
Invention
|
Inflammatory disease. The invention relates to the treatment of inflammatory diseases, and especi... |
|
|
Invention
|
Theobromine in combination with an expectorant or a mucolytic for use in therapy. An agent compri... |
|
|
Invention
|
Treatment of respiratory disorders. This invention relates to the treatment of respiratory disord... |
|
2010
|
Invention
|
Combination of theobromine with a decongestant and its use for the treatment of cough. An agent c... |
|
|
Invention
|
Therapeutic combinations of theobromine and an antihistamine. An agent comprises theobromine and ... |
|
|
Invention
|
Drug combination with theobromine and its use in therapy. An agent comprises theobromine and anot... |
|
|
Invention
|
Drug combination with theobromine and its use in therapy. An agent comprises theobromine and an o... |
|
|
Invention
|
Treatment of microbial infections.
The invention provides compositions, medicaments and methods ... |
|
|
Invention
|
Treatment of microbial infections. The invention provides compositions, medicaments and methods o... |
|
|
Invention
|
Treatment of viral infections.
The invention provides compositions, medicaments and methods of t... |
|
|
Invention
|
Treatment of viral infections. The invention provides compositions, medicaments and methods of tr... |
|
|
Invention
|
Theobromine for the treatment of cough. The present invention is theobromine as an active agent t... |
|
|
Invention
|
The use of amlexanox in the therapy of neutrophil-driven diseases.
An agent, which is amlexanox,... |
|
|
Invention
|
The use of amlexanox in the therapy of neutrophil-driven diseases. An agent, which is amlexanox, ... |
|
|
Invention
|
Hydroxymorpholiness and their use for the treatment of inflammatory disorders and pain. A compoun... |
|
2008
|
Invention
|
Pharmaceutical compound.
wherein the second component is a ribosome inactivating toxin and is co... |
|
2007
|
Invention
|
Aminoalcohol derivatives and their therapeutic use.
A compound of formula (1) Including pharmace... |
|
|
Invention
|
Peptides sequences and compositions.
Provided is a polypeptide having no more than 100 amino aci... |
|
|
Invention
|
Use of bupropion metabolites for the treatment of inflammatory disorders. Compounds that may be u... |
|
|
Invention
|
Use of beta-aminoalcohols in the treatment of inflammatory disorders and pain. 2, or SOMe; or a s... |
|
2006
|
Invention
|
2-aminoalcohols for the treatment of neurodegenerative diseases. 9 is alkyl or cycloalkyl; and n ... |
